Artemisinin Market Size, Share, Trends, Growth Outlook

Artemisinin Market is estimated to increase at a growth rate of 15.2% CAGR over the forecast period from 2024 to 2030.

The Artemisinin Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Application (Malaria, Cancer, Helminth Parasites), By Production Mechanism (Biosynthesis, Chemical Synthesis, Engineered Organisms).

An Introduction to Artemisinin Market in 2024

The Artemisinin Market in 2024 is experiencing robust growth, driven by the increasing demand for artemisinin-based antimalarial drugs, rising prevalence of malaria, and ongoing initiatives to improve access to effective malaria treatment and control measures in malaria-endemic regions worldwide. Artemisinin, a sesquiterpene lactone derived from the sweet wormwood plant (Artemisia annua), represents a cornerstone of malaria treatment, offering potent antimalarial activity against Plasmodium parasites responsible for causing malaria infection. With advancements in artemisinin extraction, purification, and formulation technologies, the market offers a range of artemisinin-based antimalarial drugs, including artemisinin monotherapies and artemisinin combination therapies (ACTs), recommended by the World Health Organization (WHO) as first-line treatments for uncomplicated malaria. Moreover, the integration of supply chain management, quality assurance practices, and public-private partnerships further enhances artemisinin availability, affordability, and accessibility in malaria-endemic regions, driving market growth and contributing to global malaria control and elimination efforts.

Artemisinin Market Trend: Increasing Adoption of Artemisinin-Based Combination Therapies (ACTs)

A prominent trend in the Artemisinin market is the increasing adoption of Artemisinin-Based Combination Therapies (ACTs) for malaria treatment. ACTs, which combine artemisinin derivatives with other antimalarial drugs, are recommended by the World Health Organization (WHO) as the first-line treatment for uncomplicated malaria. The rising prevalence of malaria, coupled with the effectiveness of ACTs in treating drug-resistant strains, is driving the demand for artemisinin as a key ingredient in these combination therapies, contributing to market growth.

Artemisinin Market Driver: Growing Global Malaria Burden and Drug-Resistant Strains

A key driver fueling the Artemisinin market is the growing global malaria burden and the emergence of drug-resistant strains. Malaria remains a significant public health challenge, particularly in regions with limited access to healthcare and preventive measures. Artemisinin, derived from the Artemisia annua plant, is renowned for its potent antimalarial properties and is instrumental in the fight against malaria. As drug-resistant strains of the malaria parasite continue to emerge, the demand for artemisinin as a crucial component of ACTs increases, propelling market expansion.

Artemisinin Market Opportunity: Advancements in Artemisinin Production and Formulation Technologies

An opportunity in the Artemisinin market lies in advancements in production and formulation technologies to enhance efficiency, scalability, and sustainability. With growing demand for artemisinin-based therapies, there is a need for innovative approaches to increase artemisinin yield, improve extraction methods, and optimize formulation processes. Biotechnological advancements, such as genetically engineered yeast and plants for artemisinin production, offer promising avenues to boost supply chain resilience and reduce dependency on traditional cultivation methods. Furthermore, research into novel drug delivery systems and formulations could lead to the development of more effective and accessible artemisinin-based therapies, addressing unmet medical needs in malaria-endemic regions and beyond.

Artemisinin Market Segmentation

By Application
Malaria
Cancer
Helminth Parasites
By Production Mechanism
Biosynthesis
Chemical Synthesis
Engineered Organisms
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Artemisinin Market Companies

Calyx Pharmaceuticals and Chemicals
Guilin Pharmaceutical Co. Ltd
Kunming Pharmaceutical Corp
Mylan Laboratories Ltd
Sanofi Aventis
Shanghai Desano Chemical Pharmaceutical Co. Ltd
Yeshua-Bio-Tech

 

 

Reasons to Buy the Artemisinin Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Artemisinin Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Artemisinin Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Artemisinin Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Artemisinin Market Size Outlook, $ Million, 2021 to 2030
3.2 Artemisinin Market Outlook by Type, $ Million, 2021 to 2030
3.3 Artemisinin Market Outlook by Product, $ Million, 2021 to 2030
3.4 Artemisinin Market Outlook by Application, $ Million, 2021 to 2030
3.5 Artemisinin Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Artemisinin Market Industry
4.2 Key Market Trends in Artemisinin Market Industry
4.3 Potential Opportunities in Artemisinin Market Industry
4.4 Key Challenges in Artemisinin Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Artemisinin Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Artemisinin Market Outlook By Segments
7.1 Artemisinin Market Outlook by Segments
By Application
Malaria
Cancer
Helminth Parasites
By Production Mechanism
Biosynthesis
Chemical Synthesis
Engineered Organisms

8 North America Artemisinin Market Analysis And Outlook To 2030
8.1 Introduction to North America Artemisinin Markets in 2024
8.2 North America Artemisinin Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Artemisinin Market size Outlook by Segments, 2021-2030
By Application
Malaria
Cancer
Helminth Parasites
By Production Mechanism
Biosynthesis
Chemical Synthesis
Engineered Organisms

9 Europe Artemisinin Market Analysis And Outlook To 2030
9.1 Introduction to Europe Artemisinin Markets in 2024
9.2 Europe Artemisinin Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Artemisinin Market Size Outlook By Segments, 2021-2030
By Application
Malaria
Cancer
Helminth Parasites
By Production Mechanism
Biosynthesis
Chemical Synthesis
Engineered Organisms

10 Asia Pacific Artemisinin Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Artemisinin Markets in 2024
10.2 Asia Pacific Artemisinin Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Artemisinin Market size Outlook by Segments, 2021-2030
By Application
Malaria
Cancer
Helminth Parasites
By Production Mechanism
Biosynthesis
Chemical Synthesis
Engineered Organisms

11 South America Artemisinin Market Analysis And Outlook To 2030
11.1 Introduction to South America Artemisinin Markets in 2024
11.2 South America Artemisinin Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Artemisinin Market size Outlook by Segments, 2021-2030
By Application
Malaria
Cancer
Helminth Parasites
By Production Mechanism
Biosynthesis
Chemical Synthesis
Engineered Organisms

12 Middle East And Africa Artemisinin Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Artemisinin Markets in 2024
12.2 Middle East and Africa Artemisinin Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Artemisinin Market size Outlook by Segments, 2021-2030
By Application
Malaria
Cancer
Helminth Parasites
By Production Mechanism
Biosynthesis
Chemical Synthesis
Engineered Organisms

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Calyx Pharmaceuticals and Chemicals
Guilin Pharmaceutical Co. Ltd
Kunming Pharmaceutical Corp
Mylan Laboratories Ltd
Sanofi Aventis
Shanghai Desano Chemical Pharmaceutical Co. Ltd
Yeshua-Bio-Tech

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Application
Malaria
Cancer
Helminth Parasites
By Production Mechanism
Biosynthesis
Chemical Synthesis
Engineered Organisms